Alzheimer's disease: Seeking new ways to preserve brain function

Geriatrics

Volumn 54, Issue 2, 1999, Pages 42-47

  Davis, Kenneth L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DONEPEZIL; ESTROGEN; GALANTAMINE; METRIFONATE; RIVASTIGMINE; TACRINE;

ALZHEIMER DISEASE; DRUG EFFECT; ENZYME INHIBITION; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; REVIEW;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS; CAREGIVERS; CHOLINESTERASE INHIBITORS; ESTROGENS; GERIATRICS; HUMANS; PRIMARY HEALTH CARE; VITAMIN E;

EID: 0032911170     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Goate AM. Molecular genetics of Alzheimer's disease. Geriatrics 1997; 52(Sept [suppl 2]):S9-12.
2. Ritchie K, Kildea D. Is senile dementia "age-related" or "aging-related"? Evidence from meta-analysis of dementia prevalence in the oldest old (see comments). Lancet 1995; 346(8980):931-4.
3. Post SG, Whitehouse PJ, Binstock RH, et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA 1997;277(10): 832-6.
4. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINCDS-AIREN International Workshop. Neurology 1993; 43:250-60.
5. Knopman D, Schneider, Davis K, Gracon S, Smith F. Long-term tacrine treatment effects. Neurology 1998; 50:567-8
6. Farlow MR, Brashear A, Hui S, Schneider L, Unverzagt F, for the Tacrine Study Group. The effects of tacrine in patients with mild versus moderate state Alzheimer's disease. In: Iqbal K, Mortimer J, Winblad B, Wisniewski H (eds). Research advances in Alzheimer's disease and related disorders. Chichester, UK: John Wiley and Sons Ltd., 1995: 284-92.
7. Sano M, Ernesto C, Thomas R, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336:1216-22.